Erratum: Suppression of CD4+ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))

Y. Y. Acosta; M. Montes-Casado; L. Aragoneses

doi:10.1177/0394632015572738

Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))

Y. Y. Acosta, M. Montes-Casado, L. Aragoneses

School of Medicine and Health Sciences

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	146
Number of pages	1
Journal	International Journal of Immunopathology and Pharmacology
Volume	28
Issue number	1
DOIs	https://doi.org/10.1177/0394632015572738
State	Published - Mar 2015

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Pharmacology

Access to Document

10.1177/0394632015572738

Cite this

Acosta, Y. Y., Montes-Casado, M., & Aragoneses, L. (2015). Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67)). International Journal of Immunopathology and Pharmacology, 28(1), 146. https://doi.org/10.1177/0394632015572738

Acosta, Y. Y. ; Montes-Casado, M. ; Aragoneses, L. / Erratum : Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67)). In: International Journal of Immunopathology and Pharmacology. 2015 ; Vol. 28, No. 1. pp. 146.

@article{10cc558e8d244efe96a878e82b60b68a,

title = "Erratum: Suppression of CD4+ T lymphocyte activation {"}in vitro{"} and experimental encephalomyelitis {"}in vivo{"} by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))",

author = "Acosta, {Y. Y.} and M. Montes-Casado and L. Aragoneses",

year = "2015",

month = mar,

doi = "10.1177/0394632015572738",

language = "English (US)",

volume = "28",

pages = "146",

journal = "International Journal of Immunopathology and Pharmacology",

issn = "0394-6320",

publisher = "Biomedical Research Press s.a.s.",

number = "1",

}

Acosta, YY, Montes-Casado, M & Aragoneses, L 2015, 'Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))', International Journal of Immunopathology and Pharmacology, vol. 28, no. 1, pp. 146. https://doi.org/10.1177/0394632015572738

Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67)). / Acosta, Y. Y.; Montes-Casado, M.; Aragoneses, L.
In: International Journal of Immunopathology and Pharmacology, Vol. 28, No. 1, 03.2015, p. 146.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Suppression of CD4+ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))

AU - Acosta, Y. Y.

AU - Montes-Casado, M.

AU - Aragoneses, L.

PY - 2015/3

Y1 - 2015/3

UR - http://www.scopus.com/inward/record.url?scp=84959311471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959311471&partnerID=8YFLogxK

U2 - 10.1177/0394632015572738

DO - 10.1177/0394632015572738

M3 - Comment/debate

AN - SCOPUS:84959311471

SN - 0394-6320

VL - 28

SP - 146

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

IS - 1

ER -

Acosta YY, Montes-Casado M, Aragoneses L. Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67)). International Journal of Immunopathology and Pharmacology. 2015 Mar;28(1):146. doi: 10.1177/0394632015572738

Erratum: Suppression of CD4+ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this

Erratum: Suppression of CD4⁺ T lymphocyte activation "in vitro" and experimental encephalomyelitis "in vivo" by the phosphatidyl inositol 3-kinase inhibitor PIK-75 (International Journal of Immunopathology and Pharmacology (2014) 27:1 (53-67))